Evidence map›Paper›PMID 36297502›Full record

ArticlePharmaceutics2022

Zsolt Kristóf Bali, Nóra Bruszt, Zsombor Kőszegi, Lili Veronika Nagy, Tamás Atlasz, Péter Kovács, Dezső Csupor, Boglárka Csupor-Löffler, István Hernádi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zsolt Kristóf BaliGrastyán Endre Translational Research Centre, University of Pécs, 6 Ifjúság Str., H-7624 Pécs, Hungary.ORCID 0000-0003-0712-0788
Nóra BrusztTranslational Neuroscience Research Group, Centre for Neuroscience, Szentágothai Research Centre, University of Pécs, 20 Ifjúság Str., H-7624 Pécs, Hungary.
Zsombor KőszegiDepartment of Experimental Zoology and Neurobiology, University of Pécs, 6 Ifjúság Str., H-7624 Pécs, Hungary.ORCID 0000-0003-2192-0159
Lili Veronika NagyGrastyán Endre Translational Research Centre, University of Pécs, 6 Ifjúság Str., H-7624 Pécs, Hungary.ORCID 0000-0001-7019-4363
Tamás AtlaszDepartment of Experimental Zoology and Neurobiology, University of Pécs, 6 Ifjúság Str., H-7624 Pécs, Hungary.ORCID 0000-0002-8112-8633
Péter KovácsDepartment of Experimental Zoology and Neurobiology, University of Pécs, 6 Ifjúság Str., H-7624 Pécs, Hungary.
Dezső CsuporDepartment of Pharmacognosy, University of Szeged, 6 Eötvös Str., H-6720 Szeged, Hungary.ORCID 0000-0002-4088-3333
Boglárka Csupor-LöfflerInstitute for Translational Medicine, Medical School, University of Pécs, 12 Szigeti Str., H-7624 Pécs, Hungary.
István HernádiGrastyán Endre Translational Research Centre, University of Pécs, 6 Ifjúság Str., H-7624 Pécs, Hungary.ORCID 0000-0001-7882-4817
University of Pecs · HUUniversity of Szeged · HU

Funding

National Research, Development and Innovation Office of the Hungarian Government 2017-1.2.1-NKP-2017-00002Richter Gedeon Centenary Fund
6 · The paper itself

Abstract

Songorine (SON) is a diterpenoid alkaloid from

Indexed as

anxietybehavioral pharmacologyditerpene alkaloidsGABA-A receptorsin vivo electrophysiologymicroiontophoresispicrotoxinsaclofensongorinevigilance

Identifiers

PMID36297502
PMCPMC9610616
OpenAlexW4297523753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.